These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2696005

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Serum concentrations of estradiol, testosterone, luteinizing hormone and hormone-stimulating hormone in men following acute myocardial infarct].
    Halawa B.
    Pol Tyg Lek; 1981 May 18; 36(20):709-10. PubMed ID: 6792605
    [No Abstract] [Full Text] [Related]

  • 25. [Insulin resistance in obese and non-obese patients with polycystic ovary syndrome. Possible role in the pathogenesis of the disease].
    Vagiri D, Barletta C, Cioli I, Scavo D.
    Minerva Endocrinol; 1994 Mar 18; 19(1):5-12. PubMed ID: 8035770
    [Abstract] [Full Text] [Related]

  • 26. Synthetic luteinizing hormone-releasing hormone: its use in the differential diagnosis of secondary oligo-amenorrhea.
    Patton WC, Thompson IE, Berger MJ, Chong AP, Taymor ML.
    Obstet Gynecol; 1974 Dec 18; 44(6):823-9. PubMed ID: 4612420
    [No Abstract] [Full Text] [Related]

  • 27. Effects of LH-RH and sex steroids on the human pituitary gonadotropin secretory function.
    Miura S, Tagawa H, Ishimaru T, Kase Y, Koga H.
    Acta Obstet Gynaecol Jpn; 1975 Jan 18; 22(1):29-36. PubMed ID: 773087
    [No Abstract] [Full Text] [Related]

  • 28. [Mechanism of the therapeutic effect of wedge resection of the ovary in Stein-Leventhal syndrome].
    Presl J.
    Cesk Gynekol; 1979 Nov 18; 44(9):698-700. PubMed ID: 509606
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of immobilization stress on gonadotropic hormones and gonadal steroid hormones].
    Yilmaz FSh.
    Zh Evol Biokhim Fiziol; 2003 Nov 18; 39(3):226-8. PubMed ID: 12973904
    [No Abstract] [Full Text] [Related]

  • 30. Effects of a cyproterone-containing oral contraceptive on hormonal levels in polycystic ovarian disease.
    Calaf-Alsina J, Rodriguez-Espinosa J, Cabero-Roura A, Lenti-Paoli O, Mora-Brugues J, Esteban-Altirriba J.
    Obstet Gynecol; 1987 Feb 18; 69(2):255-8. PubMed ID: 2949170
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Treatment of polycystic ovary syndrome].
    Jacobelli A.
    Clin Ter; 1983 Jan 31; 104(2):167-72. PubMed ID: 6861454
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Current methods of the treatment of patients with sclerocystic ovary syndrome].
    Pamfamirov IuK, Golubev VA, Ferzhaui AB.
    Akush Ginekol (Mosk); 1989 Feb 31; (2):14-7. PubMed ID: 2655483
    [No Abstract] [Full Text] [Related]

  • 37. Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles.
    Bringer J, Lefebvre P, Boulet F, Grigorescu F, Renard E, Hedon B, Orsetti A, Jaffiol C.
    Ann N Y Acad Sci; 1993 May 28; 687():115-23. PubMed ID: 8323166
    [No Abstract] [Full Text] [Related]

  • 38. Polycystic ovaries and polycystic ovary syndrome.
    Jacobs HS.
    Gynecol Endocrinol; 1987 Mar 28; 1(1):113-31. PubMed ID: 3332534
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.